Recreo Pharmaceuticals

About:

Recreo Pharmaceuticals develops resistance-modifying agents to combat antibiotic resistance.

Description:

Recreo Pharmaceuticals is the operator of a biotechnology company that develops antibodies as therapeutics for infectious diseases. The company is engaged in developing structurally unique resistance-modifying agents to combat antibiotic resistance, enabling researchers to control bacterial antibiotic resistance.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2013-01-01

Founders:

Xiang Wang

Number of Employees:

1-10

Last Funding Date:

2017-11-06

IPO Status:

Private

Industries: